Trials / Completed
CompletedNCT03111212
Iloprost in Acute Respiratory Distress Syndrome
Therapeutic Iloprost for the Treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The patients will be randomized into one of two groups. Both groups will receive standard care as is state of the art. The intervention group will receive Iloprost nebulized as inhalative therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iloprost | Iloprost nebulized |
| DRUG | control | sodium chloride 0,9% nebulized |
Timeline
- Start date
- 2019-06-25
- Primary completion
- 2021-05-14
- Completion
- 2021-08-14
- First posted
- 2017-04-12
- Last updated
- 2021-12-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03111212. Inclusion in this directory is not an endorsement.